The first Vall d'Hebron Ventures Summit took place on May 6th. It is a meeting organised by VHIR to bring together its spin-offs and their corresponding investors, with the aim of building a community among them. Although many already know each other because they have met at other events, VHIR aims to be the link that reinforces the ties and provides visibility to all the stakeholders. 

On this event, fifteen of our spin-offs were briefly presented: Imidomics (Sara Marsal, CMO), Bsure Medical (Menno Marien), Mimark Diagnostics (Marina Rigau), Endolipid Therapeutics & Endolipid Derma (David Martínez-Selva, CSO), Tensor Medical (Sergi Valverde), Frontwave (Cristina Duran),  Nora Health (Ariadna Oroval), Abcdx (Jean-Charles Sanchez), Manina Medtech (Mónica Rodríguez, vídeo), D-Sight (Carla Maté), heecap (Laura Lizama), Ysotope theranostics (Carlos Langeberg), Artis Development (Raul Guerra), Trackyourmed (Oriol Bestard). Thus, the attendees were able to get an overview of what the entrepreneurs are working on and the current stage they are at. 

The round panel ‘The 3 perspectives of an investment round’ exposed the three visions of this stage which often generates conflict between investors and entrepreneurs. Participants included Marina Rigau, CEO and co-founder of MiMARK, Laura Rodríguez, investor at Invivo Partners, and Antoni Rosselló, lawyer at RCD. In fact, lawyers also play a very significant role mediating and supporting during all the stages of the investment rounds. 

In addition, other investors were invited in order they could learn about new opportunities in this community. The event was also opened to all the Campus Vall d'Hebron researchers in order to encourage entrepreneurialism. 

This meeting was created to become an annual event of reference in the sector to facilitate the recruitment of both national as well as international investors of and for our companies. According to Rafael Navajo, Director of Innovation and Business Development at the VHIR, "it is a unique opportunity to create a network of connections between different environments, which will help us maintain our position as a reference centre in innovation management. It also allows us to continue positively impacting patient society'.